Live Quote · NASDAQKYMRHealthcare· Biotechnology

Kymera Therapeutics, Inc.

$115.31▼ 3.42%($-4.08)
MKT CAP $9.84BNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
35
Valuation
40
Profitability
10
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KYMR research report →

Analyst Price Target
$141.53+22.7% vs. today

Range $115 – $180

Analyst RatingBuy
24 Buy3 Hold0 Sell

Price Chart

+78.42% · this period
$138.86$101.56$64.27Nov 20May 26Nov 20
52-Week Range65% of range
Low
$63.69
Current
$115.31
High
$142.92